Effect of insulin on human adipose tissue metabolism in situ. Interactions with beta-adrenoceptors.
The effects of insulin, and its interactions with catecholamines through beta-adrenoceptors, on human adipose tissue glucose utilization and lipolysis were investigated in vivo. Microdialysis of the extracellular compartment of abdominal subcutaneous adipose tissue was performed in healthy subjects of normal weight, before and during a 2-h hyperinsulinaemic (61 +/- 3 mU/l), euglycaemic clamp. The tissue was perfused with or without the beta-adrenergic agonist isoproterenol (10(-6) mol/l), and the tissue dialysate concentrations of glucose, glycerol (lipolysis index) lactate and pyruvate were determined. During the insulin infusion, glucose in adipose tissue decreased by 20% (p less than 0.001), despite arterial steady-state normoglycaemia. The concentrations of lactate and pyruvate increased gradually to a steady-state plateau of twice the basal level in adipose tissue and arterial blood. Insulin-induced suppression of glycerol (lipolysis index) was, if anything, more marked in adipose tissue than in plasma (65% vs 50% decrease from baseline levels, p less than 0.05). In situ perfusion of adipose tissue with isoproterenol, starting either at the beginning of the study period or at 45 min after initiation of the insulin infusion, resulted in marked and rapid elevations of all the investigated metabolites in the adipose tissue extracellular compartment (p less than 0.05-0.005). It is concluded that insulin action on glucose uptake and lipolysis in human adipose tissue in vivo is counteracted by beta-adrenoceptor stimulation. In contrast, insulin and beta-adrenoceptors have synergistic effects on non-oxidative glucose metabolism in human adipose tissue in situ.
Hagström-Toft
E
E
Department of Medicine, Huddinge Hospital, Sweden.
Arner
P
P
Johansson
U
U
Eriksson
L S
LS
Ungerstedt
U
U
Bolinder
J
J
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D003956:Dialysis / Q000379:methods; D005260:Female; D015309:Glucose Clamp Technique; D005990:Glycerol / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000097:blood / Q000494:pharmacology*; D007332:Insulin Infusion Systems; D007545:Isoproterenol / Q000494:pharmacology*; D007700:Kinetics; D007773:Lactates / Q000378:metabolism; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D011773:Pyruvates / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology*; D012016:Reference Values; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D007773:Lactates; D011773:Pyruvates; D011943:Receptors, Adrenergic, beta; D007545:Isoproterenol; D005990:Glycerol